AMANTINI, DAVID,MESIC, MILAN,SAXTY, GORDON,POLJAK, TANJA,VUJASINOVIC, INES,ZIHER, DINKO,WITTY, DAVID,GIBSON, KARL RICHARD
申请号:
CA3069358
公开号:
CA3069358A1
申请日:
2018.07.12
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present invention relates to pyrrolopyrimidine compounds according to Formula (I) and their use in the prophylaxis and/or treatment of pain, inflammatory conditions, cardiovascular diseases, neurodegenerative diseases, neurological diseases, complications of type I diabetes, cancer and/or fibrotic diseases. In a particular aspect, the present compounds are ASK inhibitors, particularly ASK1 inhibitors. The present invention also provides methods for the production of a compound of the invention, pharmaceutical compositions comprising a compound of the invention, the use of the compounds in the prophylaxis and/or treatment of pain, inflammatory conditions, cardiovascular diseases, neurodegenerative diseases, neurological diseases, complications of type I diabetes, cancer and/or fibrotic diseases. (Formula (I))